{"id":"thallous-chloride-t1-201","safety":{"commonSideEffects":[{"rate":null,"effect":"Radiation exposure"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL1200535","moleculeType":"Small molecule","molecularWeight":"238.44"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Thallium-201 mimics potassium and is taken up by the Na+/K+-ATPase pump in viable cardiac myocytes. The distribution of the radiotracer reflects regional myocardial blood flow and cellular viability, allowing visualization of perfusion defects and ischemic or infarcted tissue. It is used in nuclear medicine imaging to assess coronary artery disease and myocardial viability.","oneSentence":"Thallous chloride T1-201 is a potassium analog that accumulates in viable myocardial tissue and is used as a radiotracer for cardiac imaging.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:11:59.563Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Myocardial perfusion imaging for detection of coronary artery disease"},{"name":"Assessment of myocardial viability in patients with coronary artery disease"}]},"trialDetails":[{"nctId":"NCT00381316","phase":"PHASE4","title":"Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2006-07","conditions":"Coronary Artery Disease","enrollment":291}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"FATIGUE"},{"count":1,"reaction":"PAIN"},{"count":1,"reaction":"PNEUMONIA"},{"count":1,"reaction":"TACHYCARDIA"},{"count":1,"reaction":"WEIGHT DECREASED"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Thallous Chloride T1-201","genericName":"Thallous Chloride T1-201","companyName":"GE Healthcare","companyId":"ge-healthcare","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Thallous chloride T1-201 is a potassium analog that accumulates in viable myocardial tissue and is used as a radiotracer for cardiac imaging. Used for Myocardial perfusion imaging for detection of coronary artery disease, Assessment of myocardial viability in patients with coronary artery disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}